DK3872058T3
(en )
2023-10-16
Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
MX2011007930A
(en )
2011-09-06
Crystalline insulin-conjugates.
PL1993985T3
(en )
2018-03-30
Process for the preparation of 1,2-propanediol
MX2014004862A
(en )
2014-05-27
Acrylic polymer formulations.
PL2252300T3
(en )
2017-04-28
Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
UA104438C2
(en )
2014-02-10
Method for the preparation of dabigatran and its intermediates
TW200617019A
(en )
2006-06-01
A process for the preparation of 7α-alkylated 19-norsteroids
IL211313A0
(en )
2011-04-28
Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
MY158910A
(en )
2016-11-30
Surface modified silicic acid semi-gels
TW200833649A
(en )
2008-08-16
Method for the preparation of hydroxyadamantanamine
MX349563B
(en )
2017-08-02
Pharmaceutical formulation of nanonised fenofibrate.
EP1996192A4
(en )
2010-10-27
Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
ZA201003264B
(en )
2013-10-30
Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane
UA42783U
(en )
2009-07-27
Method for treatment of dysbacteriosis
UA56130U
(en )
2011-01-10
method for treatment and prevention of teliasiosis
MX2009003196A
(en )
2009-04-07
Process for the preparation of î³-butyrolactones.
UA36031U
(en )
2008-10-10
Method for immunorehabilitation of patients with postinfectious astenic syndrome
UA92215C2
(en )
2010-10-11
method for annuloplication at surgical treatment of infectious endocarditis of the tricuspid valve
UA88561C2
(en )
2009-10-26
Method for obtaining antihemolitic preparation
UA35751U
(en )
2008-10-10
Using the preparation "krystal-900" as a disinfecting agent in fishery
UA35660U
(en )
2008-09-25
Use of antihomotoxic preparations as cytoprotectors
UA106224C2
(en )
2014-08-11
Crystalline insulin-conjugates
UA38295U
(en )
2008-12-25
Method for alloplasty of paracolostomic hernia in eliminating colostoma
UA60148U
(en )
2011-06-10
Method for treating non-alcoholic steatohepatitis
HK1153406A
(en )
2012-03-30
Piperlongumine and piperlongumine analogs for use in the treatment of cancer